Table 2.
Clinical Variables | Comparison vs Reference | Odds Ratio | 95% Confidence Interval | P-Value | Adjusted Odds Ratio | 95% Confidence Interval | P-Value |
---|---|---|---|---|---|---|---|
Race/Ethnicity | Asian vs White | 0.593 | 0.047–7.432 | 0.94 | |||
Black vs White | 0.405 | 0.138–1.188 | 0.42 | ||||
Other vs White | 0.720 | 0.060–8.674 | 0.91 | ||||
Osteoporosis | Yes vs No | 1.636 | 0.639–4.192 | 0.37 | |||
Tobacco History | Yes vs No | 1.195 | 0.482–2.965 | 0.70 | |||
Alcohol History | Yes vs No | 1.186 | 0.652–2.158 | 0.58 | |||
Dental Hygiene | Moderate vs Good | 0.718 | 0.288–1.792 | 0.46 | |||
Poor vs Good | 1.070 | 0.357–3.209 | 0.68 | ||||
Periodontal Disease History | Yes vs No | 0.575 | 0.253–1.307 | 0.19 | |||
Steroid Exposure | Yes vs No | 1.238 | 0.633–2.422 | 0.53 | |||
Bevacizumab Exposure | Yes vs No | 5.816 | 1.916–17.652 | 0.002 | 5.152 | 1.665–15.945 | 0.005 |
Bisphosphate agent | Pamidronate vs Zoledronic Acid | 0.244 | 0.074–0.799 | 0.04 | 0.181 | 0.033–0.974 | 0.047 |
Zoledronic & Pamidronate vs Zoledronic Acid | 0.653 | 0.283–1.507 | 0.54 | 0.580 | 0.217–1.552 | 0.28 | |
Time on Bisphosphonate | Months (reported as β-coefficient) | 0.995 | 0.982–1.007 | 0.49 |
Bold indicates statistically significant associations (p<0.05)